Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting hepatocyte growth factor receptor (Met) positive tumor cells using internalizing nanobody-decorated albumin nanoparticles.
Heukers R, Altintas I, Raghoenath S, De Zan E, Pepermans R, Roovers RC, Haselberg R, Hennink WE, Schiffelers RM, Kok RJ, van Bergen en Henegouwen PM. Heukers R, et al. Among authors: kok rj. Biomaterials. 2014 Jan;35(1):601-10. doi: 10.1016/j.biomaterials.2013.10.001. Epub 2013 Oct 16. Biomaterials. 2014. PMID: 24139763 Free article.
Targeting of liposomes to angiogenic endothelial cells.
Schiffelers RM, Molema G, Ten Hagen TL, Janssen AP, Schraa AJ, Kok RJ, Koning GA, Storm G. Schiffelers RM, et al. Among authors: kok rj. Cell Mol Biol Lett. 2002;7(2):255. Cell Mol Biol Lett. 2002. PMID: 12097939 No abstract available.
Ligand-targeted liposomes directed against pathological vasculature.
Schiffelers RM, Molema G, ten Hagen TL, Janssen AP, Schraa AJ, Kok RJ, Koning GA, Storm G. Schiffelers RM, et al. Among authors: kok rj. J Liposome Res. 2002 Feb-May;12(1-2):129-35. doi: 10.1081/lpr-120004785. J Liposome Res. 2002. PMID: 12604046
Peptide-targeted PEG-liposomes in anti-angiogenic therapy.
Janssen AP, Schiffelers RM, ten Hagen TL, Koning GA, Schraa AJ, Kok RJ, Storm G, Molema G. Janssen AP, et al. Among authors: kok rj. Int J Pharm. 2003 Mar 18;254(1):55-8. doi: 10.1016/s0378-5173(02)00682-8. Int J Pharm. 2003. PMID: 12615409
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.
Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G. Schiffelers RM, et al. Among authors: kok rj. J Control Release. 2003 Aug 28;91(1-2):115-22. doi: 10.1016/s0168-3659(03)00240-2. J Control Release. 2003. PMID: 12932643
Renal targeting of kinase inhibitors.
Dolman ME, Fretz MM, Segers GJ, Lacombe M, Prakash J, Storm G, Hennink WE, Kok RJ. Dolman ME, et al. Among authors: kok rj. Int J Pharm. 2008 Dec 8;364(2):249-57. doi: 10.1016/j.ijpharm.2008.04.040. Epub 2008 May 4. Int J Pharm. 2008. PMID: 18550305 Review.
142 results